Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4

3(42.9%)

N/A

1(14.3%)

Phase 1

1(14.3%)

Early Phase 1

1(14.3%)

Phase 2

1(14.3%)

7Total

Phase 4(3)

N/A(1)

Phase 1(1)

Early Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07247487Recruiting

Diet and Cardiometabolism in Rosario

Role: collaborator

NCT03498742Completed

Asthmatic Subjects Could Live Without Short Acting beta2 Agonists

Role: lead

NCT03216941Phase 4Completed

Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward

Role: lead

NCT02391766Early Phase 1Unknown

Group Intervention Empowerment Dementia

Role: lead

NCT01210183Phase 2Completed

Biological Response of Stage IV Knee Osteoarthritis to Serial 12.5% Dextrose

Role: lead

NCT01393431Terminated

Futility of Exhaled Breath Condensate pH Measurements in Ventilated Patients in Intensive Care Unit (ICU)

Role: lead

NCT01300754Phase 1Completed

Effectiveness of Dextrose Injection for Osgood-Schlatter Disease

Role: lead

NCT01295957Phase 4Completed

Alzheimer's Disease Reminiscence Quality of Life

Role: lead

NCT01279213Phase 4Completed

Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia

Role: lead

NCT00960830Not ApplicableCompleted

Mirtazapine Reduces ICD Shocks in ICD Patients With Depression and Anxiety

Role: lead

All 10 trials loaded